Low Mood in Winter: SAD, Vitamin D, Light Therapy, and the Full Protocol

Low Mood in Winter: SAD, Vitamin D, Light Therapy, and the Full Protocol

Every October, a predictable pattern plays out across millions of households: the clocks fall back, the days shorten, energy collapses, carbohydrate cravings spike, and the motivation that powered summer projects quietly evaporates. For some people, this is mild seasonal sluggishness. For roughly 10 million Americans — and a further 25 million who experience a subsyndromal form — it meets clinical criteria for Seasonal Affective Disorder (SAD), a recurrent major depressive episode tied to photoperiod changes (American Psychiatric Association, DSM-5).

What separates SAD from "winter blues" is duration, severity, and the involvement of specific neurobiological mechanisms: suppressed serotonin transporter activity, dysregulated melatonin secretion, and — critically — a near-universal drop in vitamin D status. Understanding these mechanisms is what allows us to build a protocol that actually addresses root causes rather than just masking symptoms.

---

Vitamin D Winter Depression: Why Sunlight Deprivation Changes Your Brain

Of all the nutritional factors linked to seasonal mood changes, vitamin D has the strongest mechanistic case. Vitamin D receptors (VDRs) are expressed throughout the brain, including in the hippocampus, prefrontal cortex, and hypothalamus — regions central to mood regulation. More specifically, vitamin D modulates the gene expression of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis, and influences serotonin synthesis indirectly via tryptophan hydroxylase-2 (Rhonda Patrick & Bruce Ames, FASEB Journal 2015; doi.org/10.1096/fj.14-268342).

During winter months at latitudes above 35°N, UVB radiation is insufficient for cutaneous vitamin D3 synthesis — sometimes for five or more months consecutively. Population studies consistently show that serum 25(OH)D levels drop 10–20 ng/mL between summer and winter in unsupplemented adults (Kasper & Wehr, Neuropsychobiology 1992). A large cross-sectional analysis from the UK Biobank (N = 31,684) found that lower 25(OH)D was independently associated with greater depressive symptom scores after adjusting for confounders (Vellekkatt & Menon, General Psychiatry 2019; doi.org/10.1136/gpsych-2018-000012).

Randomized controlled trial data is more nuanced. A 2022 Cochrane-adjacent meta-analysis of 61 RCTs concluded that supplemental vitamin D significantly improved depression scores compared to placebo, with the most pronounced effects in individuals with baseline deficiency (25(OH)D below 20 ng/mL) (Shaffer et al., Critical Reviews in Food Science and Nutrition 2020; doi.org/10.1080/10408398.2019.1693933).

Clinical dose context: Most trials showing mood benefit used 2,000–4,000 IU of vitamin D3 daily, often paired with vitamin K2 (MK-7) to support calcium partitioning. If you want to understand optimal vitamin D3 and K2 dosing and synergy, the pairing matters as much as the D3 dose itself.

Without a blood test, you're supplementing blind. This is exactly where a platform like Ones — which pulls your lab results and maps them to clinically dosed formulas — changes the calculus. Ones includes vitamin D3 paired with K2 (MK-7) at doses calibrated to your actual baseline, not a generic one-size number.

---

Serotonin Winter Mood: The Neurotransmitter at the Center of SAD

The serotonin transporter (SERT) hypothesis of SAD, first articulated by Rosenthal and later refined by Bhagya and colleagues, proposes that reduced light exposure during winter up-regulates SERT expression in the raphe nuclei — effectively vacuuming serotonin out of the synapse faster than it can exert mood-stabilizing effects. Brain imaging studies using PET have confirmed elevated SERT binding in SAD patients during symptomatic winter periods compared to summer (Neumeister et al., Archives of General Psychiatry 2006; PMID: 16520438).

This is why both light therapy and SSRIs are evidence-based first-line treatments for SAD — they both, by different mechanisms, increase synaptic serotonin availability.

From a supplement standpoint, several nutrients directly support serotonin synthesis or SERT regulation:

Tryptophan and 5-HTP: Serotonin is synthesized from dietary tryptophan via 5-hydroxytryptophan (5-HTP). A double-blind crossover trial found that tryptophan depletion worsened mood in individuals with a family history of depression under winter conditions, providing causal evidence for the serotonin-winter link (Neumeister et al., Archives of General Psychiatry 1998; PMID: 9435762). 5-HTP supplementation (100–300 mg/day) has demonstrated efficacy in depressive disorders in several European RCTs, though larger modern trials are still needed.

Saffron (Crocus sativus): Among the most compelling natural SERT modulators, saffron extract (standardized to safranal and crocin) at 30 mg/day has shown antidepressant effects comparable to fluoxetine 20 mg/day in a 6-week RCT (Akhondzadeh et al., Phytotherapy Research 2004; PMID: 15612130). A 2020 systematic review of 23 studies confirmed significant improvements in depression and anxiety scores with saffron supplementation (Marx et al., Journal of Affective Disorders 2020; doi.org/10.1016/j.jad.2020.01.065).

Magnesium: Magnesium deficiency impairs serotonin receptor function and is extremely common in Western diets — estimates suggest 50–60% of Americans fall below the Estimated Average Requirement (NIH Office of Dietary Supplements). A 6-week open-label trial in 126 adults with mild-to-moderate depression found that 248 mg of elemental magnesium per day produced clinically significant improvements in PHQ-9 scores (Tarleton et al., PLOS ONE 2017; PMID: 28654669). For those wanting to explore the sleep and mood dimensions of this mineral, magnesium glycinate benefits for sleep and anxiety covers the glycinate form specifically — which offers superior bioavailability with minimal laxative effect.

---

Omega-3 Seasonal Affective Disorder: Why Fish Oil Belongs in Your Winter Stack

Omega-3 fatty acids — specifically EPA and DHA — are among the most studied nutrients in depression research. EPA in particular appears to be the active mood-relevant fraction, with multiple meta-analyses showing that formulas delivering ≥60% EPA relative to DHA produce the largest antidepressant effect sizes (Sublette et al., Journal of Clinical Psychiatry 2011; PMID: 21939614).

The mechanism is multi-layered: EPA inhibits phospholipase A2, reducing pro-inflammatory eicosanoid production; DHA maintains neuronal membrane fluidity, supporting receptor sensitivity; and both modulate the hypothalamic-pituitary-adrenal (HPA) axis, which is chronically dysregulated in depressive disorders including SAD.

For seasonal affective disorder specifically, a 9-week Norwegian RCT found that 9.6 g/day of omega-3 (high EPA) significantly reduced depressive symptoms on the MADRS scale compared to placebo in a general depression sample that included seasonal presentations (Su et al., Journal of Clinical Psychiatry 2008; PMID: 18559048). More relevant to SAD specifically, low omega-3 index (a red blood cell measure of EPA+DHA status) has been associated with higher latitude — the same geographic factor that drives SAD prevalence (Ramsden et al., Prostaglandins, Leukotrienes & Essential Fatty Acids 2010).

Typical clinical dosing for mood support: 1,000–2,000 mg EPA+DHA daily, with a ratio favoring EPA. For a deeper breakdown of how ratio and sourcing affect outcomes, the omega-3 EPA DHA ratio guide is worth reviewing before choosing a product.

---

SAD Light Therapy Supplement Stacks: How to Combine Light and Nutrition

Light therapy — 10,000 lux full-spectrum white light for 20–30 minutes upon waking — remains the gold-standard non-pharmacological treatment for SAD. A 1998 meta-analysis of 332 patients confirmed a significant response rate of approximately 53% with morning bright light therapy (Terman et al., Neuropsychopharmacology 1998; PMID: 9603514). The American Psychiatric Association includes it as a first-line treatment.

But light therapy and supplements aren't mutually exclusive — they work on complementary pathways, and the combination may outperform either alone. Light therapy primarily resets circadian phase and suppresses melatonin. Supplements address downstream deficiencies in vitamin D, omega-3, and serotonin precursors that light therapy does not directly correct.

A practical morning SAD protocol:

1. Wake at a consistent time (circadian anchor — critical for SAD)
2. Begin 10,000 lux light therapy session within 30 minutes of waking (20–30 min duration)
3. Take vitamin D3 + K2 with breakfast (fat-soluble absorption is enhanced with food)
4. Take omega-3 EPA/DHA with largest meal of the day
5. Take magnesium glycinate in the evening (also supports sleep latency)
6. Consider 5-HTP (100 mg) or saffron (30 mg) in early afternoon if serotonin support is a priority — not within 5 hours of an SSRI
7. Maintain consistent sleep and wake times, even on weekends

Adaptogenic support can also be valuable here. Ashwagandha (KSM-66, 600 mg/day) reduces cortisol and HPA-axis hyperactivity, which is elevated in many SAD patients (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). Chronically elevated cortisol suppresses neurogenesis and serotonin receptor density — two mechanisms that compound winter depression. For more on the evidence base for this extract, clinical evidence for ashwagandha on cortisol and stress covers the KSM-66 trials in detail.

Rhodiola Rosea is another adaptogen with a direct clinical trial in depression. A 6-week RCT of standardized Rhodiola extract (340 mg/day, 3% rosavins/1% salidroside) found significant improvement in overall depression, insomnia, and emotional instability versus placebo (Darbinyan et al., Nordic Journal of Psychiatry 2007; PMID: 17990195).

---

What This Means for Your Formula

Seasonal affective disorder is a multi-system problem — involving circadian biology, serotonin neurotransmission, neuroinflammation, and nutritional deficiency. A generic winter multivitamin doesn't address this complexity. Here's where Ones takes a different approach:

Vitamin D3 + K2 (MK-7): Ones includes vitamin D3 paired with vitamin K2 as MK-7, with dosing calibrated to your actual 25(OH)D level from submitted blood work — not a blanket 1,000 IU that may be meaningless for someone starting at 14 ng/mL.

Omega-3 (EPA/DHA): Ones sources a high-EPA omega-3 formula, reflecting the meta-analytic evidence that EPA, not DHA, drives the antidepressant signal. If your dietary intake and lab markers suggest insufficiency, it's included at clinically meaningful doses.

Magnesium Complex: Ones' proprietary Magnesium Complex includes magnesium glycinate — the bioavailable, gut-friendly form used in the Tarleton 2017 depression trial — alongside other complementary magnesium forms that support sleep architecture and muscle relaxation.

Ashwagandha KSM-66 (600 mg): For users whose wearable data or health history flags high perceived stress and disrupted sleep alongside low mood, Ones can include KSM-66 ashwagandha at the full 600 mg dose validated in cortisol-reduction trials.

Adrenal Support System Blend: Ones' proprietary Adrenal Support blend is designed for individuals showing HPA-axis dysregulation signals — combining adaptogens, B vitamins, and vitamin C in a single formula that complements the mood-specific ingredients above.

The difference between Ones and platforms like Ritual or Thorne's off-the-shelf stacks is calibration. Ritual delivers the same multi to every subscriber. Thorne requires practitioner involvement and still relies on you self-selecting products. Ones uses an AI health practitioner to read your blood work, wearable trends, and stated health goals — then builds a 6, 9, or 12-capsule daily formula with doses matched to actual clinical ranges, not label minimums.

---

Key Takeaways

• SAD involves at least three distinct biological pathways — circadian disruption, serotonin transporter up-regulation, and vitamin D/omega-3 deficiency — which is why single-nutrient approaches often underperform.
• Vitamin D3 supplementation at 2,000–4,000 IU/day shows the strongest mood benefit in individuals with baseline insufficiency (below 20 ng/mL); blood testing is essential to dose correctly.
• EPA-dominant omega-3 (1,000–2,000 mg EPA+DHA, ≥60% EPA) has consistent RCT support for depressive symptoms and is especially relevant at higher latitudes where SAD prevalence is greatest.
• Light therapy (10,000 lux, 20–30 min upon waking) and supplements work through complementary pathways — they are additive, not redundant, and the strongest SAD protocols include both.
• Magnesium glycinate and saffron extract (30 mg) are evidence-backed add-ons for serotonin support and sleep quality; both have RCT data specifically in depressive presentations.
• Personalized dosing matters: a platform that reads your actual labs and calibrates each ingredient to clinical ranges will consistently outperform any fixed-formula supplement stack for seasonal mood support.

---

This article is for educational purposes only and does not constitute medical advice. Seasonal Affective Disorder is a clinical diagnosis — consult a licensed healthcare provider before making changes to your supplementation or treatment plan, especially if you are currently taking medication.